Literature DB >> 7913042

Nitric oxide has no chronotropic effect in right atria isolated from rat heart.

R H Kennedy1, K K Hicks, J E Brian, E Seifen.   

Abstract

This study was designed to determine if nitric oxide (NO) has direct effects on heart rate or if it is involved in the chronotropic actions of adrenergic or cholinergic stimulation. Right atria were isolated from hearts of adult male rats, bathed in Krebs-Henseleit buffer (37 degrees C), and used to monitor spontaneous rate. For comparison, ring segments of thoracic aorta were also suspended in the Krebs-Henseleit solution and used to examine vascular actions of various agents. The dose-dependent chronotropic effects of acetylcholine (10(-7)-10(-3) M) and norepinephrine (10(-8)-3 x 10(-4) M) in right atria were not affected by pretreatment with 10(-4) M N-nitro-L-arginine or 10(-3) M N-nitro-L-arginine-methyl ester, inhibitors of L-arginine-derived NO production. SIN-1 (3-morpholino-sydnonimine), an agent which releases NO in aqueous solution, elicited a dose-dependent (0.3-100 microM) vasorelaxation in aortic preparations constricted with 60 mM KCl; the ED50 value for this effect was increased by pretreatment with methylene blue (10 microM) and LY-83,583 (6-(phenylamino)-5,8- quinolinedione; 1 and 3 microM), compounds which inhibit NO-induced stimulation of guanylate cyclase. SIN-1 produced a negative chronotropic effect in right atria; however, this action was not observed at concentrations less than 300 microM and was not antagonized by methylene blue or LY-83,583. 8-Bromo cyclic GMP produced a dose-dependent (10-3000 microM) decrease in KCl-induced tension in aortic rings. In right atria, 8-bromo cyclic GMP elicited a positive chronotropic effect.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7913042     DOI: 10.1016/0014-2999(94)90093-0

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  9 in total

1.  Peroxynitrite is a positive inotropic agent in atrial and ventricular fibres of the frog heart.

Authors:  J M Chesnais; R Fischmeister; P F Mery
Journal:  J Physiol       Date:  1999-12-01       Impact factor: 5.182

2.  Positive and negative inotropic effects of NO donors in atrial and ventricular fibres of the frog heart.

Authors:  J M Chesnais; R Fischmeister; P F Méry
Journal:  J Physiol       Date:  1999-07-15       Impact factor: 5.182

3.  Negative inotropic actions of nitric oxide require high doses in rat cardiac muscle.

Authors:  R P Wyeth; K Temma; E Seifen; R H Kennedy
Journal:  Pflugers Arch       Date:  1996-08       Impact factor: 3.657

4.  Role of nitric oxide in regulating cardiac electrophysiology.

Authors:  L Wang
Journal:  Exp Clin Cardiol       Date:  2001

5.  Nitric oxide effects depend on different mechanisms in different regions of the rat heart.

Authors:  Kursat Derici; Ufuk Samsar; Emine Demirel-Yilmaz
Journal:  Heart Vessels       Date:  2011-02-11       Impact factor: 2.037

6.  Role of the NO-cGMP pathway in the muscarinic regulation of the L-type Ca2+ current in human atrial myocytes.

Authors:  G Vandecasteele; T Eschenhagen; R Fischmeister
Journal:  J Physiol       Date:  1998-02-01       Impact factor: 5.182

Review 7.  Regulation of myocardial calcium channels by cyclic AMP metabolism.

Authors:  L Hove-Madsen; P F Méry; J Jurevicius; A V Skeberdis; R Fischmeister
Journal:  Basic Res Cardiol       Date:  1996       Impact factor: 17.165

8.  The ineffectiveness of the NO-cyclic GMP signaling pathway in the atrial myocardium.

Authors:  H Nawrath; D Bäumner; J Rupp; H Oelert
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

9.  Interaction between neuronal nitric oxide synthase and inhibitory G protein activity in heart rate regulation in conscious mice.

Authors:  P Jumrussirikul; J Dinerman; T M Dawson; V L Dawson; U Ekelund; D Georgakopoulos; L P Schramm; H Calkins; S H Snyder; J M Hare; R D Berger
Journal:  J Clin Invest       Date:  1998-10-01       Impact factor: 14.808

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.